1. Home
  2. ELVN vs PDM Comparison

ELVN vs PDM Comparison

Compare ELVN & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • PDM
  • Stock Information
  • Founded
  • ELVN 2016
  • PDM 1997
  • Country
  • ELVN United States
  • PDM United States
  • Employees
  • ELVN N/A
  • PDM N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • PDM Building operators
  • Sector
  • ELVN Health Care
  • PDM Real Estate
  • Exchange
  • ELVN Nasdaq
  • PDM Nasdaq
  • Market Cap
  • ELVN 1.1B
  • PDM 1.1B
  • IPO Year
  • ELVN 2020
  • PDM N/A
  • Fundamental
  • Price
  • ELVN $22.12
  • PDM $8.05
  • Analyst Decision
  • ELVN Strong Buy
  • PDM Buy
  • Analyst Count
  • ELVN 5
  • PDM 4
  • Target Price
  • ELVN $41.20
  • PDM $9.00
  • AVG Volume (30 Days)
  • ELVN 613.6K
  • PDM 747.9K
  • Earning Date
  • ELVN 11-12-2025
  • PDM 10-27-2025
  • Dividend Yield
  • ELVN N/A
  • PDM 3.11%
  • EPS Growth
  • ELVN N/A
  • PDM N/A
  • EPS
  • ELVN N/A
  • PDM N/A
  • Revenue
  • ELVN N/A
  • PDM $565,372,000.00
  • Revenue This Year
  • ELVN N/A
  • PDM N/A
  • Revenue Next Year
  • ELVN $20.05
  • PDM N/A
  • P/E Ratio
  • ELVN N/A
  • PDM N/A
  • Revenue Growth
  • ELVN N/A
  • PDM N/A
  • 52 Week Low
  • ELVN $13.30
  • PDM $5.46
  • 52 Week High
  • ELVN $26.48
  • PDM $10.02
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 58.31
  • PDM 43.18
  • Support Level
  • ELVN $19.84
  • PDM $7.88
  • Resistance Level
  • ELVN $24.64
  • PDM $8.36
  • Average True Range (ATR)
  • ELVN 1.58
  • PDM 0.23
  • MACD
  • ELVN 0.28
  • PDM -0.01
  • Stochastic Oscillator
  • ELVN 70.03
  • PDM 32.09

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About PDM Piedmont Office Realty Trust Inc.

Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.

Share on Social Networks: